Regulatory Leadership As one of the largest FDA-registered parenteral injectable manufacturers for animal health in the U.S., Nova-Tech demonstrates strong regulatory compliance, making it an attractive partner for companies seeking reliable, compliant manufacturing services.

Innovation Focus With a state-of-the-art 85,000-square-foot facility dedicated to aseptic fill and multiple level 100 filling suites, Nova-Tech emphasizes technological excellence in sterile manufacturing—an opportunity for suppliers of advanced manufacturing equipment and technology solutions.

Recent Quality Concerns The voluntary recall of a Lactated Ringers Injection lot due to potential contamination indicates a focus on quality control, highlighting potential needs for enhanced testing, contamination detection, and quality assurance solutions.

Growth Potential Having reported revenues between $25M and $50M and backed by private investment, Nova-Tech presents prospects for service expansion, such as process optimization, supply chain management, and expanding product lines tailored to animal health markets.

Leadership and Investment The appointment of a new CEO and backing by private investors suggest strategic growth initiatives, creating opportunities for partnerships in areas like corporate automation, digital transformation, and compliance technology upgrades.